Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats

Doxorubicin (DOX) is a cytotoxic anthracycline antibiotic and one of the important chemotherapeutic agents for different types of cancers. DOX treatment is associated with adverse effects, particularly cardiac dysfunction. This study examined the cardioprotective effects of carvedilol (CAR) and/or r...

Full description

Bibliographic Details
Main Authors: Abeer M. Alanazi, Laila Fadda, Ahlam Alhusaini, Rehab Ahmad, Iman H. Hasan, Ayman M. Mahmoud
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/9/2/159
id doaj-9561891a714b4a4abc9f4eebc8e30de9
record_format Article
spelling doaj-9561891a714b4a4abc9f4eebc8e30de92020-11-25T02:18:24ZengMDPI AGAntioxidants2076-39212020-02-019215910.3390/antiox9020159antiox9020159Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in RatsAbeer M. Alanazi0Laila Fadda1Ahlam Alhusaini2Rehab Ahmad3Iman H. Hasan4Ayman M. Mahmoud5Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaPhysiology Division, Zoology Department, Faculty of Science, Beni-Suef University, Beni-Suef 62514, EgyptDoxorubicin (DOX) is a cytotoxic anthracycline antibiotic and one of the important chemotherapeutic agents for different types of cancers. DOX treatment is associated with adverse effects, particularly cardiac dysfunction. This study examined the cardioprotective effects of carvedilol (CAR) and/or resveratrol (RES) and liposomal RES (LIPO-RES) against DOX-induced cardiomyopathy, pointing to their modulatory effect on oxidative stress, inflammation, S100A1 and sarco/endoplasmic reticulum calcium ATPase2a (SERCA2a). Rats received CAR (30 mg/kg) and/or RES (20 mg/kg) or LIPO-RES (20 mg/kg) for 6 weeks and were challenged with DOX (2 mg/kg) twice per week from week 2 to week 6. DOX-administered rats exhibited a significant increase in serum creatine kinase-MB (CK-MB), troponin-I and lactate dehydrogenase (LDH) along with histological alterations, reflecting cardiac cell injury. Cardiac toll-like receptor 4 (TLR-4), inducible nitric oxide synthase (iNOS), tumor necrosis factor (TNF)-α and interleukin (IL)-6 protein expression were up-regulated, and lipid peroxidation was increased in DOX-administered rats. Treatment with CAR, RES or LIPO-RES as well as their alternative combinations ameliorated all observed biochemical and histological alterations with the most potent effect exerted by CAR/LIPO-RES. All treatments increased cardiac antioxidants, and the expression of S100A1 and SERCA2a. In conclusion, the present study conferred new evidence on the protective effects of CAR and its combination with either RES or LIPO-RES on DOX-induced inflammation, oxidative stress and calcium dysregulation.https://www.mdpi.com/2076-3921/9/2/159doxorubicins100a1carvedilolphenolsoxidative stresscardiomyopathy
collection DOAJ
language English
format Article
sources DOAJ
author Abeer M. Alanazi
Laila Fadda
Ahlam Alhusaini
Rehab Ahmad
Iman H. Hasan
Ayman M. Mahmoud
spellingShingle Abeer M. Alanazi
Laila Fadda
Ahlam Alhusaini
Rehab Ahmad
Iman H. Hasan
Ayman M. Mahmoud
Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats
Antioxidants
doxorubicin
s100a1
carvedilol
phenols
oxidative stress
cardiomyopathy
author_facet Abeer M. Alanazi
Laila Fadda
Ahlam Alhusaini
Rehab Ahmad
Iman H. Hasan
Ayman M. Mahmoud
author_sort Abeer M. Alanazi
title Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats
title_short Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats
title_full Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats
title_fullStr Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats
title_full_unstemmed Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats
title_sort liposomal resveratrol and/or carvedilol attenuate doxorubicin-induced cardiotoxicity by modulating inflammation, oxidative stress and s100a1 in rats
publisher MDPI AG
series Antioxidants
issn 2076-3921
publishDate 2020-02-01
description Doxorubicin (DOX) is a cytotoxic anthracycline antibiotic and one of the important chemotherapeutic agents for different types of cancers. DOX treatment is associated with adverse effects, particularly cardiac dysfunction. This study examined the cardioprotective effects of carvedilol (CAR) and/or resveratrol (RES) and liposomal RES (LIPO-RES) against DOX-induced cardiomyopathy, pointing to their modulatory effect on oxidative stress, inflammation, S100A1 and sarco/endoplasmic reticulum calcium ATPase2a (SERCA2a). Rats received CAR (30 mg/kg) and/or RES (20 mg/kg) or LIPO-RES (20 mg/kg) for 6 weeks and were challenged with DOX (2 mg/kg) twice per week from week 2 to week 6. DOX-administered rats exhibited a significant increase in serum creatine kinase-MB (CK-MB), troponin-I and lactate dehydrogenase (LDH) along with histological alterations, reflecting cardiac cell injury. Cardiac toll-like receptor 4 (TLR-4), inducible nitric oxide synthase (iNOS), tumor necrosis factor (TNF)-α and interleukin (IL)-6 protein expression were up-regulated, and lipid peroxidation was increased in DOX-administered rats. Treatment with CAR, RES or LIPO-RES as well as their alternative combinations ameliorated all observed biochemical and histological alterations with the most potent effect exerted by CAR/LIPO-RES. All treatments increased cardiac antioxidants, and the expression of S100A1 and SERCA2a. In conclusion, the present study conferred new evidence on the protective effects of CAR and its combination with either RES or LIPO-RES on DOX-induced inflammation, oxidative stress and calcium dysregulation.
topic doxorubicin
s100a1
carvedilol
phenols
oxidative stress
cardiomyopathy
url https://www.mdpi.com/2076-3921/9/2/159
work_keys_str_mv AT abeermalanazi liposomalresveratrolandorcarvedilolattenuatedoxorubicininducedcardiotoxicitybymodulatinginflammationoxidativestressands100a1inrats
AT lailafadda liposomalresveratrolandorcarvedilolattenuatedoxorubicininducedcardiotoxicitybymodulatinginflammationoxidativestressands100a1inrats
AT ahlamalhusaini liposomalresveratrolandorcarvedilolattenuatedoxorubicininducedcardiotoxicitybymodulatinginflammationoxidativestressands100a1inrats
AT rehabahmad liposomalresveratrolandorcarvedilolattenuatedoxorubicininducedcardiotoxicitybymodulatinginflammationoxidativestressands100a1inrats
AT imanhhasan liposomalresveratrolandorcarvedilolattenuatedoxorubicininducedcardiotoxicitybymodulatinginflammationoxidativestressands100a1inrats
AT aymanmmahmoud liposomalresveratrolandorcarvedilolattenuatedoxorubicininducedcardiotoxicitybymodulatinginflammationoxidativestressands100a1inrats
_version_ 1724882395158544384